Page 135 - MSU Digital Book
P. 135
11. Uwaezuoke SN, Muoneke UV, Mbanefo NR. The supportive treatment of IgA
nephropathy and idiopathic nephrotic syndrome: how useful are omega-3
polyunsaturated fatty acids? Int J Nephrol Renovasc Dis. 2020;13:27-35.
12. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, et al.
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous
nephropathy. N Engl J Med 1984;310:946–50.
13. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, et al. A randomized, controlled
trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused
by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18:1899–904.
14. Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
Comparative effectiveness and tolerance of immunosuppressive treatments
for idiopathic membranous nephropathy: A network meta-analysis. PLoS One.
2017;12:e0184398.
15. Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, et al. Idiopathic minimal change
nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
Nephrol Dial Transplant. 2003;18:1316-20.
16. Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults
with nephrotic syndrome. Cochrane Database Syst Rev. 2008:CD001537.
17. Korbet SM. Clinical picture and outcome of primary focal segmental
glomerulosclerosis. Nephrol Dial Transplant. 1999;14 Suppl 3:68-73.
18. Beer A, Mayer G, Kronbichler A. Treatment strategies of adult primary focal
segmental glomerulosclerosis: A systematic review focusing on the last two
decades. Biomed Res Int. 2016;2016:4192578.
19. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, et al.
Clinical trial of focal segmental glomerulosclerosis in children and young adults.
Kidney Int. 2011;80:868-78.
20. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immunosuppressive treatment of
membranoproliferative glomerulonephritis. Nephron. 1994;67:59-65.
21. Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A. Treatment of
idiopathic membranoproliferative glomerulonephritis with mycophenolate
mofetil and steroids. Nephrol Dial Transplant 2004;19:3160–4.
110

